MiR-483-5p suppresses the proliferation of glioma cells via directly targeting ERK1. (Q39371347)

11 September 2017

MiR-483-5p suppresses the proliferation of glioma cells via directly targeting ERK1. (English)

1 reference

11 September 2017

Li Wang

1

1 reference

11 September 2017

Ming Shi

2

1 reference

11 September 2017

Shuangxing Hou

3

1 reference

11 September 2017

Bojun Ding

4

1 reference

11 September 2017

Lijuan Liu

5

1 reference

11 September 2017

Xituan Ji

6

1 reference

11 September 2017

Jian Zhang

7

1 reference

11 September 2017

Yanchun Deng

8

1 reference

11 September 2017

language of work or name

English

0 references

publication date

27 March 2012

1 reference

11 September 2017

1 reference

11 September 2017

586

1 reference

11 September 2017

9

1 reference

11 September 2017

1312-1317

1 reference

MicroRNAs: genomics, biogenesis, mechanism, and function

11 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.03.035

MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.03.035

MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.03.035

MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.03.035

Significance analysis of microarrays applied to the ionizing radiation response

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.03.035

Real-time quantification of microRNAs by stem-loop RT-PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.03.035

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.03.035

A system for stable expression of short interfering RNAs in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.03.035

miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.03.035

microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.03.035

Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.03.035

miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.03.035

MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.03.035

MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.03.035

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.03.035

Expression profiling identifies microRNA signature in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.03.035

A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.03.035

The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.03.035

The MEK/ERK cascade: from signaling specificity to diverse functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.03.035

MiR-483-5p controls angiogenesis in vitro and targets serum response factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.03.035

The MAP kinase pathway is required for entry into mitosis and cell survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.03.035

ERK2 but not ERK1 plays a key role in hepatocyte replication: an RNAi-mediated ERK2 knockdown approach in wild-type and ERK1 null hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.03.035

10.1016/J.FEBSLET.2012.03.035

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference